The target genes analyzed in this study (e.g., ITGB1, TIMP3, and BRAF) were selected based on their strong prognostic relevance identified from cBioPortal survival analyses of high-grade serous ovarian carcinoma. The gene discussed is BRAF; the disease is ovarian serous carcinoma.